Is Pulse Biosciences (PLSE) stock Halal?

Pulse Biosciences is a bioelectric medicine company that leverages its novel Nano-Pulse Stimulation technology to treat a variety of medical conditions. This technology employs precise pulses of electrical energy to stimulate cells, primarily aimed at dermatology and oncology applications. Pulse Biosciences focuses on developing innovative solutions that provide significant clinical benefits, offering non-thermal and non-invasive treatment options. For Muslim investors, though, the most pressing question is simpler: is Pulse Biosciences a Halal investment?

Is Pulse Biosciences Shariah compliant?

No. In the October 2026 screening Pulse Biosciences (PLSE) does not pass AAOIFI screening: it fails the non-permissible income screen. Medicines and medical devices are permissible, and healthcare companies like Pulse Biosciences usually clear the activity screen comfortably. What AAOIFI Shariah Standard No. 21 watches is the financing behind the pipeline: drug development is expensive, and the 30% interest bearing debt cap decides the verdict more often than the science does.

Does Pulse Biosciences pass the business activity test?

The activity screen is only part of the picture this month: Pulse Biosciences currently fails the non-permissible income screen, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.

Is Pulse Biosciences' income Halal?

No. Pulse Biosciences' income from impermissible sources currently exceeds AAOIFI's 5% revenue ceiling, which makes the stock non-compliant on this screen regardless of the others. The screen is reassessed monthly, so the status can change when new financial statements arrive.

Does Pulse Biosciences meet AAOIFI's debt and investment ratio requirements?

Yes. Both caps hold this month: interest bearing investments and interest bearing debt each stay below 30% of market capitalisation, measured against a market capitalisation of $3.56B (market data as of 1 October 2026). Because the caps move with the share price, our Shariah Supervisory Board has PLSE re-screened every month, and the result above always shows the latest verdict.

Why do other halal screeners show a different verdict for Pulse Biosciences?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance